Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $29.33 million. The enterprise value is $18.87 million.

Market Cap	29.33M
Enterprise Value	18.87M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Annovis Bio has 19.49 million shares outstanding. The number of shares has increased by 35.60% in one year.

Current Share Class	19.49M
Shares Outstanding	19.49M
Shares Change (YoY)	+35.60%
Shares Change (QoQ)	+6.31%
Owned by Insiders (%)	14.45%
Owned by Institutions (%)	8.17%
Float	15.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.29
P/TBV Ratio	3.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.59

Current Ratio	3.59
Quick Ratio	2.72
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3,159.09% and return on invested capital (ROIC) is -2,143.41%.

Return on Equity (ROE)	-3,159.09%
Return on Assets (ROA)	-138.26%
Return on Invested Capital (ROIC)	-2,143.41%
Return on Capital Employed (ROCE)	-265.76%
Revenue Per Employee	n/a
Profits Per Employee	-$1.64M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.90% in the last 52 weeks. The beta is 1.51, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y)	1.51
52-Week Price Change	-86.90%
50-Day Moving Average	1.73
200-Day Moving Average	6.17
Relative Strength Index (RSI)	48.41
Average Volume (20 Days)	440,066

Short Selling Information

The latest short interest is 2.02 million, so 10.36% of the outstanding shares have been sold short.

Short Interest	2.02M
Short Previous Month	1.68M
Short % of Shares Out	10.36%
Short % of Float	12.89%
Short Ratio (days to cover)	7.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.69M
Pretax Income	-47.53M
Net Income	-24.59M
EBITDA	n/a
EBIT	-26.69M
Earnings Per Share (EPS)	-$2.31

Full Income Statement

Balance Sheet

The company has $10.55 million in cash and n/a in debt, giving a net cash position of $10.55 million or $0.54 per share.

Cash & Cash Equivalents	10.55M
Total Debt	n/a
Net Cash	10.55M
Net Cash Per Share	$0.54
Equity (Book Value)	9.31M
Book Value Per Share	0.66
Working Capital	10.04M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-21.89M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.60%
Shareholder Yield	-35.60%
Earnings Yield	-83.57%
FCF Yield	n/a

Analyst Forecast

The average price target for Annovis Bio is $37.00, which is 2,358.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.00
Price Target Difference	2,358.47%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-36.15%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2